Controlled studies in pregnant women show no evidence of fetal risk. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk. Animal studies show risk and human studies not available or neither animal nor human studies done. Contact the applicable plan provider for the most current information. D: Use in LIFE-THREATENING emergencies when no safer drug available. Adverse effect of hydroxychloroquine Discoid lupus and plaquenil Plaquenil and light sensitivity to eyes Plaquenil and hyperpigmentation Chloroquine is the generic form of the brand-name prescription medicine Aralen, which is used to prevent and treat malaria — a mosquito-borne disease caused by a parasite — and to treat amebiasis, an infection of the intestines caused by a parasite. Group antimalarial agent Tablet 100 mg, 150 mg, 300 mg base as phosphate or sulfate Syrup 50 mg base as phosphate or sulfate in 5 ml Injection 50 mg, 100 mg base as phosphate or sulfate per ml in 2-ml ampoule chloroquine base 150 mg is equivalent to chloroquine sulfate 200 mg or Chloroquine phosphate 250 mg CN 250 Chloroquine Phosphate 250 mg Pill with imprint CN 250 is White, Round and has been identified as Chloroquine Phosphate 250 mg. It is supplied by Rising Pharmaceuticals Inc. Chloroquine is used in the treatment of malaria; amebiasis; malaria prevention and belongs to the drug classes amebicides, antimalarial quinolines. FDA has not. Active against erythrocytic forms of Plasmodium vivax & P. malariae and most strains of Plasmodium falciparum Precise mechanism not known Bioavailability: ~89% Peak plasma time: 1-2 hr Distributed widely in body tissues (eg, eyes, heart, kidneys, liver, lungs) where retention prolonged; crosses placenta; enters breast milk Partially in liver Half-life: 3-5 days Excretion: urine (~70% as unchanged drug); acidification of urine increases elimination Small amounts may be present in urine months following discontinuation of therapy The above information is provided for general informational and educational purposes only. Chloroquine phosphate 250 mg malaria Guidelines for Treatment of Malaria in the United States., WHO Model Prescribing Information Drugs Used in Parasitic. Shortness of breath related to plaquenilHydroxychloroquine plaquenil tablet 200 mg dose 200 mg freq bidCan swollen ankles be caused by hydroxychloroquineHydroxychloroquine flu vaccineHydroxychloroquine cost Chloroquine Phosphate Tablets are an antimalarial and amebicidal drug. Each tablet, for oral administration, contains 250 mg chloroquine phosphate equivalent to 150 mg base or 500 mg chloroquine phosphate equivalent to 300 mg base. CHLOROQUINE PHOSPHATE TABLETS, USP 250 MG. CN 250 Chloroquine Phosphate 250 mg -. Aralen chloroquine Malaria Drug Side Effects & Dosage. WHAT ARE CHLOROQUINE PHOSPHATE TABLETS BP 250 MG USED FOR? Chloroquine Phosphate is one of a group of medicines called anti malarials, which are used in the prevention and suppression of malaria. When prescribed by a doctor it may also be used to treat malaria. When used to prevent malaria, official guidelines and local information on Chloroquine Phosphate. CHLOROQUINE is used to treat or prevent malaria infections. It is also used to treat amebiasis. The lowest GoodRx price for the most common version of chloroquine phosphate is around $23.11, 75% off the average retail price of $93.55. Usual Adult Dose for Malaria Prophylaxis. 500 mg chloroquine phosphate 300 mg base orally on the same day each week Comments-If possible, suppressive therapy should start 2 weeks prior to exposure; if unable to start 2 weeks before exposure, an initial loading dose of 1 g chloroquine phosphate 600 mg base may be taken orally in 2 divided doses, 6 hours apart.